In triple-negative breast cancer cells, NFκΒ is activated downstream of PTPRZ1 following PTN binding, although the signaling that leads to NFκΒ activation is not clarified [15]. This evidence concerns the gene PTPRZ1 and triple-negative breast carcinoma.